These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9972849)

  • 21. Release of acetylcholinesterase and aminopeptidase in vivo following infusion of amphetamine into the substantia nigra.
    Greenfield SA; Shaw SG
    Neuroscience; 1982; 7(11):2883-93. PubMed ID: 7155357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemistry of somatodendritic dopamine release in substantia nigra: an in vivo comparison with striatal dopamine release.
    Heeringa MJ; Abercrombie ED
    J Neurochem; 1995 Jul; 65(1):192-200. PubMed ID: 7790860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the behavioural effects of infusion of carbachol and acetylcholinesterase into the rat substantia nigra.
    Hawkins CA; Greenfield SA
    Pharmacol Biochem Behav; 1996 Sep; 55(1):67-80. PubMed ID: 8870040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 17β-Estradiol infusions into the dorsal striatum rapidly increase dorsal striatal dopamine release in vivo.
    Shams WM; Sanio C; Quinlan MG; Brake WG
    Neuroscience; 2016 Aug; 330():162-70. PubMed ID: 27256507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-cholinergic effects of acetylcholinesterase in the substantia nigra: a possible role for an ATP-sensitive potassium channel.
    Webb CP; Greenfield SA
    Exp Brain Res; 1992; 89(1):49-58. PubMed ID: 1350999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of amphetamine and 6-hydroxydopamine lesions on reserpine-induced oral dyskinesia.
    Neisewander JL; Castañeda E; Davis DA; Elson HJ; Sussman AN
    Eur J Pharmacol; 1996 Jun; 305(1-3):13-21. PubMed ID: 8813526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rotenone increases glutamate-induced dopamine release but does not affect hydroxyl-free radical formation in rat striatum.
    Leng A; Feldon J; Ferger B
    Synapse; 2003 Dec; 50(3):240-50. PubMed ID: 14515342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subthalamic responses to amphetamine and apomorphine in the behaving rat with a unilateral 6-OHDA lesion in the substantia nigra.
    Olds ME; Jacques DB; Kopyov O
    Synapse; 1999 Dec; 34(3):228-40. PubMed ID: 10523760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Origin of various enzymes released from the substantia nigra and caudate nucleus: effects of 6-hydroxydopamine lesions of the nigro-striatal pathway.
    Greenfield SA; Grünewald RA; Foley P; Shaw SG
    J Comp Neurol; 1983 Feb; 214(1):87-92. PubMed ID: 6404955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Motor activity-induced dopamine release in the substantia nigra is regulated by muscarinic receptors.
    Andersson DR; Björnsson E; Bergquist F; Nissbrandt H
    Exp Neurol; 2010 Jan; 221(1):251-9. PubMed ID: 19944096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3-Methoxytyramine formation following monoamine oxidase inhibition is a poor index of dendritic dopamine release in the substantia nigra.
    Elverfors A; Pileblad E; Lagerkvist S; Bergquist F; Jonason J; Nissbrandt H
    J Neurochem; 1997 Oct; 69(4):1684-92. PubMed ID: 9326297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cortical cholinergic deficiency enhances amphetamine-induced dopamine release in the accumbens but not striatum.
    Mattsson A; Olson L; Svensson TH; Schilström B
    Exp Neurol; 2007 Nov; 208(1):73-9. PubMed ID: 17714706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uptake of acetylcholinesterase by neurons in the substantia nigra.
    Dickie BG; Budd TC; Vaux D; Greenfield SA
    Eur J Neurosci; 1995 Mar; 7(3):351-7. PubMed ID: 7773434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship between visual stimulation, behaviour and continuous release of protein in the substantia nigra.
    Jones SA; Ellis JR; Klegeris A; Greenfield SA
    Brain Res; 1991 Sep; 560(1-2):163-6. PubMed ID: 1760724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations in amphetamine stereotypy following acute lesions of substantia nigra.
    Gonzalez LP
    Life Sci; 1987 Mar; 40(9):899-908. PubMed ID: 3546989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Amphetamine-induced hyperfunction of the dopaminergic system and delta sleep-inducing peptide].
    Popova NS; Dovedova EL
    Ross Fiziol Zh Im I M Sechenova; 1998; 84(1-2):24-9. PubMed ID: 9612853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between dopaminergic neurons, acetylcholinesterase and nicotinic acetylcholine receptors containing the alpha3- or alpha5-subunit in the rat substantia nigra.
    Emmett SR; Greenfield SA
    J Chem Neuroanat; 2005 Jul; 30(1):34-44. PubMed ID: 15975762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence that [3H]dopamine is taken up and released from nondopaminergic nerve terminals in the rat substantia nigra in vitro.
    Kelly E; Jenner P; Marsden CD
    J Neurochem; 1985 Jul; 45(1):137-44. PubMed ID: 3923157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GABA(B) receptors modulate depolarization-stimulated [³H]glutamate release in slices of the pars reticulata of the rat substantia nigra.
    Cortés H; Paz F; Erlij D; Aceves J; Florán B
    Eur J Pharmacol; 2010 Dec; 649(1-3):161-7. PubMed ID: 20863782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychopharmacological evidence for a role of the ATP-sensitive potassium channel in the substantia nigra of the rat.
    Lévesque D; Greenfield SA
    Neuropharmacology; 1991 Apr; 30(4):359-65. PubMed ID: 1852269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.